scispace - formally typeset
Open AccessJournal ArticleDOI

Comparison of the Elecsys Anti-SARS-CoV-2 immunoassay with the EDI™ enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma.

Reads0
Chats0
TLDR
A head-to-head comparison of the fully-automated Elecsys® Anti-SARS-CoV-2 immunoassay with the EDITM enzyme linked immunosorbent assays (ELISA) for the detection of SARS- CoV- 2 antibodies in human plasma indicates a high sensitivity and specificity for the ElecsYS® assay and an acceptable agreement with the EditorialM ELISAs.
About
This article is published in Clinica Chimica Acta.The article was published on 2020-10-01 and is currently open access. It has received 99 citations till now. The article focuses on the topics: Immunoassay.

read more

Citations
More filters
Journal ArticleDOI

COVID-19: a review

TL;DR: This review of the COVID-19 pandemic aims to offer a comprehensive and thorough explanation of the disease, including its significance and impact on surgery, by drawing information from the most up to date and relevant sources available.
Journal ArticleDOI

SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons.

TL;DR: Serological response to SARS-CoV-2 in outpatients including asymptomatic persons is less pronounced than in hospitalized patients, and a lower viral load is suggested as a possible explanation for lower rate of seropositivity.
Journal ArticleDOI

A comparative review of immunoassays for COVID-19 detection.

TL;DR: A literature review on the databases of PubMed, Scopus and Google Scholar between January 1, 2020 and June 30, 2020 based on the main serological methods for COVID-19 detection with the focus on comparative experiments was performed as discussed by the authors.
Journal ArticleDOI

Comparison of eight commercial, high-throughput, automated or ELISA assays detecting SARS-CoV-2 IgG or total antibody.

TL;DR: Compared the performance of assays detecting IgG or total antibodies to N or S antigens, validated for routine use in France, with samples from subjects with more or less severe SARS-CoV-2 infection, discrepancies occurred, without a systematic origin.
References
More filters
Journal ArticleDOI

Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.

TL;DR: The findings provide strong empirical support for the routine application of serological testing in the diagnosis and management of COVID-19 patients and offer vital clinical information during the course of SARS-CoV-2 infection.
Journal ArticleDOI

Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia.

TL;DR: Two 1-step quantitative real-time reverse-transcription PCR assays can achieve a rapid detection of 2019n-CoV in human samples, thereby allowing early identification of patients.
Related Papers (5)